Onconetix Ratios (2023-2025) | ONCO

Ratios Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 26.98%14.29%25.91%92.70%45.10%66.20%88.55%
EBT Margin 3,208.13%1,986.98%11,861.89%-1,604.74%-2,022.55%-954.58%-4,263.67%-8,408.82%-2,227.77%-2,892.70%
EBIT Margin 3,107.35%1,667.83%11,694.91%-1,582.16%-1,931.62%-650.32%-4,093.66%-12,369.21%-1,817.40%-681.45%
EBITDA Margin 3,208.13%1,986.98%10,592.34%-2,277.88%-2,018.89%-107.14%-4,659.47%-8,300.32%-135.84%-2,945.97%
Operating Margin 3,107.35%1,667.83%11,694.91%-1,582.16%-1,931.62%-650.32%-4,093.66%-12,369.21%-1,817.40%-681.45%
Net Margin 3,208.13%1,986.98%11,855.21%-1,587.39%-2,029.76%-940.72%-4,163.73%-9,560.15%-2,536.24%-2,892.70%
FCF Margin 3,689.36%1,129.84%2,287.08%-747.63%-456.44%-282.38%-130.02%-1,967.92%-1,324.00%-1,050.56%
Efficiency
Inventory Average 1.30M0.89M0.38M0.28M0.14M0.09M0.11M0.15M0.15M
Assets Average 26.12M28.81M57.70M81.27M67.25M60.69M45.05M23.48M18.95M19.40M
Equity Average 16.38M11.66M5.82M-6.55M-21.61M6.15M24.78M6.27M4.95M4.64M
Invested Capital 19.71M13.09M10.25M1.41M-14.50M-28.73M41.15M8.54M3.99M5.91M4.36M
Asset Utilization Ratio -0.010.000.010.030.060.080.070.06
Leverage & Solvency
Interest Coverage Ratio -31.07-16.68-116.95-58.95-66.37-11.42-117.36-56.22-8.68-6.90
Debt to Equity 0.000.040.000.09-0.010.000.010.29
Debt Ratio 0.000.020.000.000.000.000.000.05
Equity Ratio 0.880.440.370.02-0.19-0.480.660.300.210.310.17
Times Interest Earned -31.07-16.68-116.95-58.95-66.37-11.42-117.36-56.22-8.68-6.90
Valuation
Enterprise Value -22.26M-9.22M-7.65M2.45M2.57M6.15M6.77M-0.65M-1.60M-0.30M-0.84M
Return Ratios
Return on Sales 32.08%19.87%118.62%-15.87%-20.30%-9.41%-41.35%-84.09%-22.28%-28.93%
Return on Capital Employed -0.89%-0.74%-1.10%-1.14%-2.11%-6.14%-7.40%-14.77%
Return on Invested Capital -2.23%
Return on Assets -0.65%-0.56%-0.79%-0.85%-1.30%-2.39%-2.33%-2.53%
Return on Equity -6.43%6.98%2.46%-8.40%-2.37%-8.95%-8.92%-10.59%